, Volume 63, Issue 4, pp 425–435 | Cite as

Anticancer effects of 6-o-palmitoyl-ascorbate combined with a capacitive-resistive electric transfer hyperthermic apparatus as compared with ascorbate in relation to ascorbyl radical generation

  • Shinya Kato
  • Ryoko Asada
  • Katsuhiro Kageyama
  • Yasukazu Saitoh
  • Nobuhiko MiwaEmail author
Original Research


The aim of the present study is to determine the anti-proliferative activity of 6-o-palmitoyl-l-ascorbic acid (Asc6Palm) that is a lipophilic derivative of l-ascorbic acid (Asc), on human tongue squamous carcinoma HSC-4 cells by combined use of hyperthermia in comparison to Asc. Asc6Palm or Asc were administered to HSC-4 cells for 1 h, to which hyperthermia at 42 °C was applied for initial 15 min. After further 1–72 h incubation at 37 °C, cell proliferation was determined with Crystal Violet staining. Ascorbyl radical (AscR) in HSC-4 cell suspension was measured by electron spin resonance (ESR), and cell morphology was observed with scanning electron microscopy (SEM). At 37 °C, 4 mM Asc or 0.35 mM Asc6Palm were enough to suppress proliferation of HSC-4 cells. By combined use of hyperthermia at 42 °C, cell proliferation was decreased when compared to 37 °C. After Asc of 4 mM was incubated with HSC-4 cell suspensions at 37 °C or 42 °C for 0–180 min, the signal intensity of ascorbyl radical (AscR) by ESR was not different regardless of the presence or absence of cells at 37 °C, whereas AscR signal was enlarged in the presence of HSC-4 cells at 42 °C. It was suggested that oxidation of Asc occurred rapidly in HSC-4 cells by hyperthermia, and thereby enhanced the anti-proliferative activity. By SEM observation, the surface of HSC-4 cells treated with Asc6Palm revealed distinct morphological changes. Thus, the combined regimen of Asc6Palm and hyperthermia is expected to exert a marked antitumor activity.


6-o-Palmitoyl-l-ascorbic acid Hyperthermia Human tongue squamous carcinoma cells HSC-4 Crystal Violet staining Electron spin resonance (ESR) Scanning electron microscopy (SEM) 



6-o-palmitoyl-l-ascorbic acid


l-ascorbic acid


Ascorbyl radical


Electron spin resonance


Scanning electron microscopy

CRet system

Capacitive-resistive transfer system


  1. Cameron E, Pauling L, Leibovitz B (1979) Ascorbic acid and cancer. Cancer Res 39:663–681Google Scholar
  2. Chen P, Yang LL, Wang YS, Li G, Fang F, Liu K, Li J, Zhao X, Hu HZ, Wei YQ (2008) Synergistic antitumor effect of CXCL10 with hyperthermia. J Cancer Res Clin Oncol 134:679–687CrossRefGoogle Scholar
  3. Chitnis MP, Adwankar MK (1986) Enhancement of the in vitro cytotoxicity of bouvardin by verapamil alone and combined with hyperthermia in Sarcoma 180 and Ehrlich ascites carcinoma cells. J Cancer Res Clin Oncol 112:131–134CrossRefGoogle Scholar
  4. Cress AE, Culver PS, Moon TE, Garner EW (1982) Correlation between amounts of cellular membrane components and sensitivity to hyperthermia in a variety of mammalian cell lines in culture. Cancer Res 42:1716–1721Google Scholar
  5. Currie RW, White FP (1981) Trauma-induced protein in rat tissues: a physiological role for a “heat shock” protein? Science 214:72–73CrossRefGoogle Scholar
  6. Dietzel F (1983) Basic principles in hyperthermic tumor therapy. Recent Results Cancer Res 86:177–190Google Scholar
  7. Dodd NJ (1973) Some EPR signals in tumour tissue. Br J Cancer 28:257–262CrossRefGoogle Scholar
  8. Dodd NJ, Swartz HM (1984) The nature of the ESR signal in lyophilized tissue and its relevance to malignancy. Br J Cancer 49:65–71CrossRefGoogle Scholar
  9. Engin K (1996) Biological rationale and clinical experience with hyperthermia. Control Clin Trials 17:316–342CrossRefGoogle Scholar
  10. Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G (2005) Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 9:361–367Google Scholar
  11. Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167–175CrossRefGoogle Scholar
  12. Gillies RJ, Didier N, Denton M (1976) Determination of cell number in monolayer cultures. Anal Biochem 159:109–113CrossRefGoogle Scholar
  13. Giovanella BC, Stehlin JS, Yim SO (1980) Correlation of the thermosensitivity of cells to their malignant potential. Ann N Y Acad Sci 335:206–214CrossRefGoogle Scholar
  14. Hacker MP, Khokhar AR, Brown DB, McCormack JJ, Kracoff IH (1985) Ascorbate (1, 2-diaminocyclohexane): platinum (II) complexes, a new series of water-soluble antitumor drugs. Cancer Res 45:4748–4753Google Scholar
  15. Hernández-Bule ML, Trillo MA, Cid MA, Leal J, Ubeda A (2007) In vitro exposure to 0.57-MHz electric currents exerts cytostatic effects in HepG2 human hepatocarcinoma cells. Int J Oncol 30:583–592Google Scholar
  16. Kageyama K, Onoyama Y, Kimura M, Yamazaki H, Miwa N (1991) Enhanced inhibition of DNA synthesis and release of membrane phospholipids in tumour cells treated with a combination of acylated ascorbate and hyperthermia. Int J Hyperthermia 7:85–91CrossRefGoogle Scholar
  17. Kageyama K, Onoyama Y, Otani S, Matsui-Yuasa I, Nagao N, Miwa N (1995) Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density. Cancer Biochem Biophys 14:273–280Google Scholar
  18. Kageyama K, Onoyama Y, Otani S, Kimura M, Matsui-Yuasa I, Nagao N, Miwa N (1996) Promotive action of acylated ascorbate on cellular DNA synthesis and growth at low doses in contrast to inhibitory action at high doses or upon combination with hyperthermia. J Cancer Res Clin Oncol 122:41–44CrossRefGoogle Scholar
  19. Kampinga HH (2006) Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int J Hyperthermia 22:191–196CrossRefGoogle Scholar
  20. Kusumoto K, Kageyama K, Matsuda T, Tomura TT, Munakata H, Tanaka H, Yazama F, Miwa N (2007) Effects of ethyl-esterization, chain length, unsaturation degrees, and hyperthermia on carcinostatic effect of omega-hydroxylated fatty acids. Exp Oncol 29:106–110Google Scholar
  21. Liu JW, Nagao N, Kageyama K, Miwa N (2000) Anti-metastatic effect of an autooxidation-resistant and lipophilic ascorbic acid derivative through inhibition of tumor invasion. Anticancer Res 20:113–118Google Scholar
  22. Liu JW, Kayasuga A, Nagao N, Masatsuji-Kato E, Tuzuki T, Miwa N (2003) Repressions of actin assembly and RhoA localization are involved in inhibition of tumor cell motility by lipophilic ascorbyl phosphate. Int J Oncol 23:1561–1567Google Scholar
  23. Lohmann W, Holz D (1984) Structure of ascorbic acid and its biological function. I. ESR determination of the ascorbyl radical in biological samples and in model systems. Biophys Struct Mech 10:197–204CrossRefGoogle Scholar
  24. Miwa N, Yamazaki H (1986) Potentiated susceptibility of ascites tumor to acyl derivatives of ascorbate caused by balanced hydrophobicity in the molecule. Exp Cell Biol 54:245–249Google Scholar
  25. Miwa N, Yamazaki H, Ikari Y (1986) Enhancement of ascorbate cytotoxicity by chelation with ferrous ions through prolonged duration of the action. Anticancer Res 6:1033–1036Google Scholar
  26. Miwa N, Yamazaki H, Nagaoka Y, Kageyama K, Onoyama Y, Matsui-Yuasa I, Otani S, Morisawa S (1988) Altered production of the active oxygen species is involved in enhanced cytotoxic action of acylated derivatives of ascorbate to tumor cells. Biochim Biophys Acta 97:144–151CrossRefGoogle Scholar
  27. Pajonk F, Ophoven A, McBride WH (2005) Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res 65:4836–4843CrossRefGoogle Scholar
  28. Pauling L (1991) Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice. Am J Clin Nutr 54:1252S–1255SGoogle Scholar
  29. Pauling L, Willoughby R, Reynolds R, Blaisdell BE, Lawson S (1982) Incidence of squamous cell carcinoma in hairless mice irradiated with ultraviolet light in relation to intake of ascorbic acid (vitamin C) and of D, L-alpha-tocopheryl acetate (vitamin E). Int J Vitam Nutr Res Suppl 23:53–82Google Scholar
  30. Pennacchioli E, Fiore M, Gronchi A (2009) Hyperthermia as an adjunctive treatment for soft-tissue sarcoma. Expert Rev Anticancer Ther 9:199–210CrossRefGoogle Scholar
  31. Roginsky VA, Stegmann HB (1994) Ascorbyl radical as natural indicator of oxidative stress: quantitative regularities. Free Radic Biol Med 17:93–103CrossRefGoogle Scholar
  32. Satoh K, Sakagami H, Nakamura K (1996) Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia. Anticancer Res 16:2987–2991Google Scholar
  33. Shammari MA, Watmough DJ, Kerr CL, Gregory DW, Wheatley DN (1990) Combined effects of hyperthermia (to 45 degrees C) and ultrasound irradiation on the surface ultrastructure of HeLa cells. Int J Hyperthermia 6:571–580CrossRefGoogle Scholar
  34. Silcock JM, Dodd NJ (1976) ESR study of changes during development of solid Yoshida tumour I: Ascorbyl radical. Br J Cancer 34:550–555CrossRefGoogle Scholar
  35. Stich HF, Wei L, Whiting RF (1979) Enhancement of the chromosome-damaging action of ascorbate by transition metals. Cancer Res 39:4145–4151Google Scholar
  36. Symonds RP, Wheldon TE (1984) Morphological changes in L1210 leukaemic cells induced by hyperthermia. Scan Electron Microsc Pt 2:825–830Google Scholar
  37. Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Sugimachi K (2002) Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 131:S78–S84CrossRefGoogle Scholar
  38. Tanaka H, Kageyama K, Kusumoto K, Asada R, Miwa N (2007) Antitumor and anti-invasive effects of diverse new macrocyclic lactones, alkylolides and alkenyloides, and their enhancement by hyperthermia. Oncol Rep 18:1257–1262Google Scholar
  39. van Bree C, van der Maat B, Ceha HM, Franken NA, Haveman J, Bakker PJ (1999) Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis. J Cancer Res Clin Oncol 125:549–555CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Shinya Kato
    • 1
    • 3
  • Ryoko Asada
    • 2
  • Katsuhiro Kageyama
    • 2
  • Yasukazu Saitoh
    • 1
    • 4
  • Nobuhiko Miwa
    • 1
    • 5
    Email author
  1. 1.Laboratory of Cell-Death Control BioTechnology, Faculty of Life and Environmental SciencesPrefectural University of HiroshimaHiroshimaJapan
  2. 2.Osaka Butsuryo CollegeOsakaJapan
  3. 3.Radioisotope CentreOsaka City University Graduate School of MedicineOsakaJapan
  4. 4.Laboratory of Bioscience & Biotechnology for Cell Function Control, Faculty of Life and Environmental SciencesPrefectural University of HiroshimaHiroshimaJapan
  5. 5.Department of Radiological Technology, Faculty of Health SciencesButsuryo College of OsakaOsakaJapan

Personalised recommendations